
The Urology Department is responsible for the medical and surgical treatment of pathologies associated with the male and female urinary tract and the male genitalia.
Its activities are essentially diagnosis and treatment and the monitoring of cancerous and non-cancerous conditions affecting the prostate, kidneys, bladder and male genitalia.
As our work is principally oncological in nature, we operate a strongly multidisciplinary approach to the treatment of all cancerous conditions associated with the genitourinary system.
Our team therefore works in close and constant collaboration with the Institut Bordet’s medical oncologists, radiotherapists, radiologists, nuclear medicine specialists and anatomopathologists.
The Institut Bordet Urology Department treats :
- prostate conditions:
- diagnosis of all prostate diseases
- treatment of benign prostate hypertrophia
- refinement (diagnosis) of prostate cancers via different examinations including biopsies conducted on an out-patient basis and under local anaesthesia
- hormone treatments
- surgical treatments mainly via robotic surgery
- focused ultrasound prostate treatment.
- Bladder conditions:
- treatment of incontinence problems (surgery, rehabilitation, urodynamic testing, etc)
- treatment of common bladder infections (for example, cystitis)
- diagnosis and treatment of bladder polyps (via fluorescent light)
- diagnosis and surgical treatment of malignant bladder tumours (cancers) with bladder reconstruction in cases of total organ ablation.
- Kidney and ureteral conditions:
- diagnosis and treatment of infectious diseases of the kidney (pyelonephritis, for example), renal calculi (kidney stones), etc.
- diagnosis and treatment of benign kidney tumours (cysts, for example)
- diagnosis and treatment of malignant tumours (cancers) of the kidney
- robotic surgery.
- Conditions affecting the male genitalia:
- diagnosis and treatment of cancerous and non-cancerous tumours of the penis and testicles
- laser treatment and sentinel node technique.
The Institut Bordet Urology Department is at the leading edge of fusion imaging, targeting and focused prostate cancer treatments (MRI – ultrasound – high frequency ultrasound).
Thanks to advances in medical imaging, in particular magnetic resonance imaging of the prostate, it is now possible to define suspect areas within the prostate. The Institut Bordet is the first centre to offer fusion imaging software. This software makes it possible to achieve very high precision guidance of the biopsies needed to characterise cancer. This fusion imaging is then exported in order to carry out focused treatment of the affected zones using high-energy ultrasound, thus allowing non-invasive, transrectal treatment of prostate cancer.
Our team
Head of Department
Dr A. Peltier
Assistant Heads of Clinic
Dr E. Hawaux
Dr K. Limani
Resident
Dr R. Diamand
Consultants
Prof. T. Roumeguère
Dr G. Assenmacher
Dr T. Quackels
Dr S. Albisinni
Assistants
Dr A. Mattlet
Dr R. Abou Zahr
Coordinator Nurse
C. Dekeyser
Administrative Secretary and Secretary of the Head of Service
Victoria Alcazar
Tel : 02/541.31.74
Secretary (appointments, reception)
Y. Bayraktar
Tel : 02/541.34.48
07/03/2022
Scientific publications
Antibody-Drug Conjugates in Prostate Cancer: Where Are we?
Authors : Mjaess G, Aoun F, Rassy E, Diamand R, Albisinni S, Roumeguère T
Year : 2023
Journal : Clin Genitourin Cancer
Volume : 21
Pages : 171-174
Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.
Authors : Oderda M, Albisinni S, Benamran D, Calleris G, Ciccariello M, Dematteis A, Diamand R, Descotes JL, Fiard G, Forte V, Giacobbe A, Marquis A, Marra G, Messas A, Muto G, Peltier A, Rius L, Simone G, Roumeguere T, Faletti R, Gontero P
Year : 2023
Journal : Prostate
Volume : 83
Pages : 162-168
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.
Authors : Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S
Year : 2023
Journal : World J Urol
Volume : 41
Pages : 77-84
Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study.
Authors : Windisch O, Benamran D, Dariane C, Favre MM, Djouhri M, Chevalier M, Guillaume B, Oderda M, Gatti M, Faletti R, Colinet V, Lefebvre Y, Bodard S, Diamand R, Fiard G
Year : 2023
Journal : Eur Urol Open Sci
Volume : 47
Pages : 94-101
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Authors : Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S
Year : 2023
Journal : Prostate